Valgen Medtech's DragonFly™ System Receives EU Approval for FMR Indication
FRANKFURT, Germany and HANGZHOU, China, June 24, 2026 /PRNewswire/ -- Valgen Medtech recently announced that its proprietary DragonFly™ Transcatheter Mitral Valve Repair System has received CE mark approval in the European Union for the treatment of Functional Mitral Regurgitation (FMR)....
FRANKFURT, Germany and HANGZHOU, China, June 24, 2026 /PRNewswire/ -- Valgen Medtech recently announced that its proprietary DragonFly™ Transcatheter Mitral Valve Repair System has received CE mark approval in the European Union for the treatment of Functional Mitral Regurgitation (FMR)....
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.